Drugs Made In America Acquisition II Corp.
DMIIU- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002040475
No open-market purchases or sales by Drugs Made In America Acquisition II Corp. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $35.0M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −3 vs. previous quarter
- 11
- 13F valueReported value at the end of Q2 2026
- $35.0M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding DMIIU, Q2 2026
No superinvestor reported holding DMIIU at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Drugs Made In America Acquisition II Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 (view filing) | Sep 26 | 5 daysLate | Stockwell LynnCEO and Exe. Chair of Board | PPurchase | +700.0K | – | – | +4.9%15.1M after | Duplicate filing |
| Oct 1, 2025 (view filing) | Sep 26 | 5 daysLate | Stockwell LynnCEO and Exe. Chair of Board | SSale | −7.97M | – | – | −54.3%6.71M after | Duplicate filing |
| Oct 1, 2025 (view filing) | Sep 26 | 5 daysLate | Stockwell LynnCEO and Exe. Chair of Board | PPurchase | +70.0K | – | – | –700.0K after | Derivative |
| Oct 1, 2025 (view filing) | Sep 26 | 5 daysLate | Drugs Made In America Acquisition II LLC10% Owner | PPurchase | +700.0K | – | – | +4.9%15.1M after | |
| Oct 1, 2025 (view filing) | Sep 26 | 5 daysLate | Drugs Made In America Acquisition II LLC10% Owner | SSale | −7.97M | – | – | −54.3%6.71M after | |
| Oct 1, 2025 (view filing) | Sep 26 | 5 daysLate | Drugs Made In America Acquisition II LLC10% Owner | PPurchase | +700.0K | – | – | –700.0K after | Derivative |
Top 10 13F holders, Q2 2026
The largest institutional positions in Drugs Made In America Acquisition II Corp. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LMR Partners LLP | 2,000,000 | $20.3M | 0.15% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 502,914 | $5.11M | 0.26% | 00.0% | Unchanged |
| Verition Fund Management LLC | 250,000 | $2.54M | 0.02% | 00.0% | Unchanged |
| BlueCrest Capital Management Ltd | 250,000 | $2.54M | 0.11% | 00.0% | Unchanged |
| Walleye Capital LLC | 100,000 | $1.02M | 0.00% | 00.0% | Unchanged |
| L1 Global Manager Pty Ltd | 100,000 | $1.02M | 0.82% | 00.0% | Unchanged |
| Readystate Asset Management LP | 100,000 | $1.02M | 0.04% | 00.0% | Unchanged |
| HRT Financial LP | 99,725 | $1.01M | 0.00% | −275−0.3% | Reduced |
| Rangeley Capital, LLC | 32,551 | $330.7K | 0.31% | −23,061−41.5% | Reduced |
| Clear Street Group Inc. | 8,084 | $82.1K | 0.00% | −158,558−95.1% | Reduced |